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Abstract
Objective: Comparing the efficiency of ultrasound therapy (US) versus extracorporeal 
shock wave therapy (ESWT) on pain and perceived health in men with bilateral knee 
osteoarthritis (OA). Design: A pilot randomized trial with concealed allocation, assessor 
blinding and intention-to-treat analysis was conducted.
Participants: 60 men, 44–66 years old were randomized to an experimental (US) and a 
control (ESWT) group. Intervention: The participants in both groups attended 5-week 
treatments. The experimental group received continuous US and a series of 10 treatments 
two times per week. The control group received 5 ESWT treatments once per week. 
Outcome measures: The primary outcome was  visual analogue scale (VAS) pain rat-
ings. The secondary outcome measured perceived health using the Western Ontario and 
McMaster Universities Osteoarthritis Index (WOMAC). The examinations were taken 
before and after the treatment. Results: After 5-week treatment the experimental group 
had significantly worse scores than the control group on the VAS for pain, and on the 
WOMAC for perceived health. Conclusion: Patients with knee OA can achieve signifi-
cant better health benefits caused by ESWT than by US.
Keywords: ultrasound, extracorporeal shock wave therapy, pain, perceived health, 
randomized trial
1. Introduction
Osteoarthritis (OA) is a chronic and degenerative disease and is considered to be one of the 
most common musculoskeletal disorders. Joints found in our body can be affected by OA. All 
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the patients with OA have almost the same symptoms, including pain, stiffness, articular insta-
bility, limitation of motion and physical activity, and muscle weakness [1, 2]. Physiotherapy 
is one of the treatments that provides effective nonpharmacological interventions for people 
with knee OA, and procedures prescribed by physiotherapists are considered to be important 
and to play a fundamental role in patients’ treatment. The most common types of electro-
therapy are ultrasound (US), transcutaneous electrical nerve stimulation (TENS), and now 
more often appearing extracorporeal shock wave therapy (ESWT). US, as a noninvasive treat-
ment is used to create a controlled, microtrauma to local affected tissue in order to stimulate a 
healing response and microvascularization [3, 4]. The first use of ESWT was not for musculo-
skeletal disorders but to break up kidney stones. It was a coincident that someone noticed an 
osteoblastic response pattern during studies at animals in the 1980s [5]. Recently, ESWT has 
been used for pain relief and musculoskeletal disorders’ treatment. It turned out that ESWT is 
also a noninvasive treatment, and the effectiveness of this method is comparable to surgery. 
It has not yet been fully explained how it exactly works, but it probably involves microde-
structions—the application of ESWT causes microbreaks in avascular or poorly vascularized 
tissue, thus stimulating appropriate revascularization and stem cell growth. It also induces 
the release of enzymes, which affect nociceptors, resulting in localized analgesia, giving the 
significant reduction of activity limitations and short duration of the treatment [6].
Despite the advances in the treatment, there is lack of comparative studies on the effects of US 
and ESWT in patients with knee OA. Therefore, the purpose of this study was to evaluate the 
effects of US versus ESWT protocol on pain measured by visual analogue scale (VAS), and on 
perceived health measured by WOMAC [7, 8] in men suffering from bilateral knee OA.
In our study we took hypothesis: there are differences between US and ESWT in reducing of 
pain, and improving perceived health in men suffering from bilateral knee OA.
Therefore the research question was
1. Is US more effective than ESWT on pain and perceived health in men with bilateral knee 
OA?
2. Method
2.1. Design
It was a randomized trial with concealed allocation, assessor blinding, and intention-to-treat 
analysis. The participants with knee OA were assessed for eligibility by an independent phy-
sician who was not involved into the study. The randomization into an experimental group 
(US) and a control group (ESWT) with a 1:1 ratio was generated by permuted block random-
ization using the website www.random.org. The randomization was achieved by having the 
participant selected one from 60 sealed opaque envelopes, each containing a group allocation, 
which had been prepared and shuffled by an independent investigator who was not involved 
into the recruitment or assessment of the participants. The researchers responsible for assess-
ing the outcomes and analyzing the data were blinded to the type of the treatment procedure. 
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To keep the assessors blinded the participants were reminded before each measurement not 
to reveal the nature of their treatment. The participants were considered to be unaware of the 
group allocation because they were informed about the existence of two intervention groups 
but not about the study hypothesis. The data were obtained at baseline and 5 weeks later 
(immediately after the intervention period).
2.2. Participants and center
The inclusion criteria for participation in the study were: minimum age of 40, not currently 
receiving any physical therapy treatments for the knee OA condition, medication compliance 
(all patients were taking glucocorticoids at the time of the study), and the diagnosis of bilat-
eral knee OA according to the American College of Rheumatology criteria [9].
The exclusion criteria were: any rheumatic disease (with the exception of bilateral knee OA), 
unilateral knee OA, skin changes, neurological disorders, mental illness, cancer, endocrinol-
ogy disease, or previous knee surgery.
The evaluations of this study were conducted at the Physiotherapy Outpatient Department of 
the Regional Hospital in Zywiec, Poland. This study was designed with respect for the rules of 
conducting experimental studies with humans after the approval by the Bioethical Committee 
at the Holycross College in Kielce, and were consistent with the Helsinki Declaration of 1975 
as revised in 2000. All participants signed consent forms knowingly participation in the study.
2.3. Intervention
The participants in both groups attended 5-week treatments. The experimental group received 
continuous US waves: intensity, 0.8 W/cm2; 100% fill; carrier frequency, 1 MHz. The patients 
received a series of 10 treatments 2 times per week. The treatments were performed using a 
US 13 EVO Cosmogamma (Emildue, Italy). The patients lied in a supine position. The acoustic 
gel, that was applied, did not contain any pharmacologically active substance. The medial 
and lateral parts of the knee were treated with US applied in circular movements. To ensure 
the best absorption of the energy the probe was put at right angles. Each treatment session 
did not last longer than 10 minutes. During the treatment the patients received neither any 
anesthetic nor other physical actions. No adverse events were observed during the treatment. 
The same therapist made US to all the participants.
The control group received ESWT − 1000 pulses during the first treatment, 1500 during the 
second and the third treatments, and 2000 during the fourth and the fifth treatments, respec-
tively (pressure, 2.5 bar; frequency, 8 Hz; energy density, 0.4 mJ/mm2). The patients received 
5 ESWT treatments once per week. The treatments were performed using a Rosetta ESWT 
(CR Technology, Korea). The patients were placed in a supine position with the affected 
knee unbent or flexed at 90°, and an acoustic gel that did not contain any pharmacologically 
active substance was applied. The shockwave probe was held stationary on a trigger point 
around the knee or at the patellofemoral and tibiofemoral borders of the target knee, avoid-
ing direct placement on the peroneal nerve or vessel. Each treatment session did not exceed 
10 minutes. During the treatments, the patients did not receive any other physical method. 
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No adverse events were observed during the treatment. The same therapist made ESWT to 
all the participants.
All of the treatments were performed at the Physiotherapy Outpatient Department of the 
Regional Hospital in Zywiec, Poland. Once a week for 5 weeks, the treatments were admin-
istered by an independent researcher who was not involved into this study. The same phys-
iotherapist with a postgraduate degree in physiotherapy and 10 years’ experience provided 
all the interventions to both (the experimental and the control) groups, and remained blind to 
primary and secondary outcome measures throughout the trial. The independent researcher 
analyzed the results/data also being blind to all of outcome measures throughout the trial.
2.4. Outcome measures
Primary outcome: The pain was assessed using a visual analogue scale (VAS), and a Laitinen 
scale. VAS is a line of 10 cm, the leftmost side is 0 = no pain and the far right is 10 = unbearable 
pain. The participants marked the scale of their current level of pain after their usual daily 
activities. The values in centimeters were recorded for statistical analysis. The same therapist 
administrated the measurements of all the participants and was blinded to the treatment.
Secondary outcome: In order to identify a specific index of disability there was used the 
WOMAC as a subjective measure of perceived health. It is a questionnaire that consists of 
three parts of questions and can be filled in a few minutes. There were 24 questions: about 
pain (5 questions), about stiffness (2 questions), and about physical function (17 questions) 
[10, 11]. In our study, we used a more detailed Likert scale version of the WOMAC, which 
includes a five-point scale for patients to mark (0 = none, 1 = mild, 2 = moderate, 3 = severe, 
and 4 = extreme). Achieving higher score means lower level of perceived health. All the scores 
were summed and coded. Answering the questions the patients described their stays during 
the past 3 days. The same therapist made the measurements to all the participants and was 
blinded to the treatment.
2.5. Data analysis
A priori sample size was determined in this study, giving the anticipated Cohen's d effect 
size of 0.8, the probability level of 5%, and the desired statistical test power level of 80%. We 
estimated that we needed minimum 26 participants in each group. The data were analyzed 
with descriptive as mean, standard deviation (SD) of two groups, mean (SD) within-group 
differences, 95% CI (95% confidence interval) of mean between-group differences, and infer-
ential techniques. The mean within-group differences and the mean between-group differ-
ences (95% CI) were calculated for each of the outcomes based on the change scores (i.e., after 
minus before scores). The Shapiro-Wilk test identified the nonnormal distribution of the VAS 
and of the WOMAC data. The mean between-group differences for data was analyzed using 
the Mann-Whitney U test. To describe the differences in related treatments, the effect size 
between-group difference was calculated using Cohen’s d, and classified as small (d = 0.2), 
moderate (d = 0.5), and large (d = 0.8) [12]. The level of statistical significance was set at a two-
tailed p-value of 0.05. The analyses were performed by a blinded and independent statistician 
according to a prespecified statistical analysis plan on an intention-to-treat basis [13].
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3. Results
3.1. Flow of participants through the study
A total of 75 participants that were admitted with bilateral knee OA between February and 
March 2016 were screened for inclusion. Fifteen patients were excluded based on the eligi-
bility criteria. Therefore, the study reports the data of 60 participants. All of them agreed 
to participate and they were subsequently randomized: 30 in the experimental group (US) 
and 30 in the control group (ESWT), as presented in Figure 1. The baseline characteristics of 
participants are shown in Table 1 and in the first two columns of data in Table 2 and Table 3. 
No important differences in these characteristics were noted between the experimental and 
control groups.
3.2. Compliance with the study protocol
During the treatments the patients did not receive any anesthetic or any other physical actions. 
No participants received the wrong intervention. No adverse events were observed during the 
treatment. All the participants were analyzed in the group to which they had been randomly 
allocated.
3.3. Effect of intervention
Primary outcome: After the intervention in both, the experimental (US) and the control (ESWT), 
groups reduce of pain severity on VAS were identified. Pain severity decreased in the right 
knee, as well as in the left knee by the mean of 3 cm (±1) in the US group, whereas the ESWT 
group decreased in the right knee by the mean of 4 cm (±2), and in the left knee by the mean 
of 5 cm (±2). The significant between-group differences on the VAS score in the right knee and 
the left one were found. The ESWT group had lower score of pain severity on the VAS in the 
right and the left knees, by the mean of 2 cm (95% CI 1–3, p < 0.001, Cohen d = 0.63), and (95% 
CI 1–3, p < 0.000, Cohen d = 1.26), respectively. The effect size for pain on VAS was medium in 
the right knee and large in the left one, as presented in Table 1.
Secondary outcome: Regarding secondary outcomes, after the intervention in both, the experi-
mental (US) and the control (ESWT), groups improvement of perceived health on WOMAC 
were identified. The domain “pain” (P) improved by the mean of 4 points (±2), the domain 
“stiffness” (ST) improved by the mean of 2 points (±2), the domain “physical function” (PF) 
improved by the mean of 17 points (±10), and the total score on WOMAC improved by the 
mean of 22 points (±11) in the US group. The ESWT group improved domain P by the mean of 
10 points (±4), improved domain ST by the mean of 5 points (±1), improved domain PF by the 
mean of 29 points (±17), and improved the total score on WOMAC by the mean of 43 points 
(±20). The significant between-group differences were found. The ESWT group had better 
scores on the WOMAC for the domain P, by the mean of 6 points (95% CI 3–9, p < 0.000, Cohen 
d = 1.90), for domain ST, by the mean of 3 points (95% CI 2–5, p = 0.002, Cohen d = 1.90), for 
domain PF, by the mean of 12 points (95% CI 1–22, p = 0.001, Cohen d = 0.86). Consequently, 
a significant between-group difference on WOMAC was identified for total score of perceived 
health, with the mean of 20 points (95% CI 7 to 33, p = 0.002, Cohen d = 1.30) in favor for the 
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Figure 1. Recruitment and flow of participants through the trial.
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ESWT group. The effect size was large for perceived health on WOMAC, as presented in 
Table 1.
All of the outcomes show that greater reduce of pain severity leads to the better perceived 
health, which promotes generally better quality of life in the participants from the ESWT 
group than in the participants from the US group, as presented in Tables 2 and 3.
4. Discussion
A number of researches considered several aspects related to muscle function, such as strength 
and aerobic capacity as well as other clinical aspects, such as pain, stiffness, range of motion of 
the knee, and WOMAC in patients with OA [14–20].
Pain is one of the most common complaints and disability symptoms in patients with knee 
OA. The positive effects of nonpharmacologic management on knee pain and health status in 
OA patients were examined. Mascarin et al. [4] studied 40 patients and compared the TENS 
protocol with the US protocol. The TENS was applied using a frequency of 100 Hz, pulse 
width of 50 μs, intensity (mA) set at the individual subject's sensorial threshold, modula-
tion up to 50% of variation frequency, quadratic biphasic symmetrical pulse and a length 
of application of 20 minutes. The US protocol consisted of continuous ultrasonic waves of 1 
Characteristic Group Group
Exp (n = 30) Con (n = 30)
Age (yr) mean (SD) 55.2 (6.3) 55.8 (5.8)
Height (m) mean (SD) 1.75 (0.06) 1.77 (0.05)
Mass (kg) mean (SD) 74.5 (3.9) 75.8 (3.6)
BMI (kg/m2) mean (SD) 24.15 (0.95) 24.35 (0.90)
Obese patients yes/no (n) 0/15 0/15
Level of education (n):
Primary school graduates 3 5
Secondary school graduates 7 6
University graduates 5 4
Occupation:
Physical worker/white-collar worker (n) 10/5 8/7
Duration of work (yr) mean (SD) 19.8 (6.1) 21.8 (5.6)
Duration of symptoms (yr) mean (SD) 8.9 (1.7) 8.3 (1.1)
Exp = ultrasound, US; Con = extracorporeal shock wave therapy (ESWT).
Table 1. Characteristics of the participants.
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Groups Difference 
within groups
Difference between groups
Before After After–Before After–Before
Exp (n = 30) Con (n = 30) Exp (n = 30) Con (n = 30) Exp (n = 30) Con (n = 30) Exp (n = 30)–Con (n = 30) p Effect size (Cohen’s d)
VAS
Right knee 6 6 3 2 –3 –4 2 0.001 0.63
(1) (2) (1) (2) (1) (2) (1–3)
Left knee 6 6 3 1 –3 –5 2 0.000 1.26
(1) (2) (1) (1) (1) (2) (1–3)
Exp = ultrasound, US; Con = extracorporeal shock wave therapy (ESWT); VAS = visual analogue scale.
Table 2. Mean (SD) of the groups, mean (SD) differences within the groups, and mean (95% CI) differences between the groups for VAS (in cm) outcomes.
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Groups Difference 
within 
groups
Difference between groups
Before After After–Before After–Before
Exp (n = 30) Con (n = 30) Exp (n = 30) Con (n = 30) Exp (n = 30) Con (n = 30) Exp (n = 30)–Con (n = 30) p Effect size (Cohen’s d)
WOMAC
P 14 14 10 4 –4 –10 6 0.000 1.90
(4) (5) (5) (2) (2) (4) (3–9)
ST 7 7 5 2 –2 –5 3 0.002 1.90
(1) (2) (3) (1) (2) (1) (2–5)
PF 52 52 34 23 –17 –29 12 0.001 0.86
(14) (18) (15) (13) (10) (17) (1–22)
Total 72 73 50 29 –22 –43 20 0.002 1.30
(18) (23) (21) (15) (11) (20) (7–33)
Exp = ultrasound, US; Con = extracorporeal shock wave therapy (ESWT); WOMAC = Western Ontario and McMaster Universities Osteoarthritis Index; P = pain; 
ST = stiffness; PF = physical function.
Table 3. Mean (SD) of the groups, mean (SD) differences within the groups, and mean (95% CI) differences between the groups for WOMAC (in points) outcomes.
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wMHz frequency and 0.8 W/cm2 power, applied with a 5-cm diameter applicator. The study 
results showed that TENS, as well as US, are effective for reducing pain and improving the 
WOMAC score. Ng et al. [21] studied 24 patients and compared electroacupuncture treatment 
and TENS, using the same parameters for both (low frequency = 2 Hz, continuous mode, 
pulsation of 200 μs for 20 minutes of application) and showed that either electroacupuncture 
treatment or TENS is effective in pain reduction because a prolonged analgesic effect main-
tained in the two groups.
Recently, ESWT has become one of the leading therapeutic alternatives. It can treat such dis-
eases as chronic tendinopathies, nonunion of long bone fracture, and early stage of avascular 
necrosis of the formal head [22]. Moreover, ESWT diffused to the treatment of OA in ani-
mals [23, 24]. It improved the rats’ walking ability [23]. It significantly improved the lameness 
degree in horses [24].
The results achieved in people only confirm these findings. Zhao et al. [25] used ESWT to 
treat knee OA over 12 weeks and compared it with placebo treatment. Seventy patients were 
randomized to receive either placebo (n = 36) or ESWT (n = 34). In the ESWT group, the 
patients received 4000 pulses of shockwave at 0.25 mJ/mm2 a week during 4 weeks. In the 
placebo group, the patients got shockwave at 0 mJ/mm2 in the same area for the same time. 
The authors found the effect on OA by pain on VAS and perceived of health on WOMAC. The 
evaluation was performed at baseline and after 1, 4, and 12 weeks. The authors found that 
ESWT was more effective than placebo in reducing pain and improving perceived of health at 
each time assessment of the research.
In our study following 5 weeks of the treatment the results were similar to the results of the 
other authors, although we applied another treatment protocol. We found that pain in knees 
decreased in both the experimental (US) and the control (ESWT) groups, but there were the 
significant between-group differences after the intervention in favor for ESWT, and also the 
effects sizes were always more far-reaching in the patients treated with ESWT, than those 
ones in the patients treated with US. In this study, we also found that both treatment meth-
ods improved the total score of WOMAC, but the health benefits in the patients treated with 
ESWT and their effect size were also more important than those ones in the patients from the 
US group.
Our study had as strengths as limitations. The strengths included the fact that the study was 
analyzed using the intention-to-treat principle, the patients were randomly assigned to the 
two groups—an experimental and a control one. The interventions were provided by the 
same blinded to outcome measures experienced physiotherapist. Also, they were adminis-
tered by the same assistant, blind to the group allocation.
The major limitation was the short follow-up period. Therefore, the future study ought to be 
a minimal follow up of 1–2 years for all subjects, it would significantly increase the impact 
of this kind of the study, unfortunately we had no chances to prolong the study. The second 
limitation is the small sample size. Our findings are therefore to be read as preliminary ones 
in view of possible future long-term studies with a larger sample size to confirm these results 
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and assess the impact of US and ESWT on pain and on perceived health in people suffering 
from knee OA.
5. Conclusion
Despite all the limitations of this study, the obtained results may be valuable for doctors, 
physiotherapists, and patients with knee OA in choosing the most appropriate types of 
treatment based on the patients’ preference and convenience. Among the people, who were 
treated for knee OA, ESWT led to greater benefits in reduce pain and perception of health, 
than a protocol which included US.
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